Total Compensation FY2022
$3.3M
As reported in 2023 DEF 14A proxy filing with the SEC
Compensation Breakdown
Base Salary
$600,000
18% of total
Stock Awards
—
0% of total
Bonus
—
0% of total
Other Compensation
$33,680
1% of total
Data Source: Compensation figures are sourced from ResMed Inc.'s DEF 14A proxy statement filed with the U.S. Securities and Exchange Commission (SEC) via EDGAR. Figures reflect total compensation for FY2022 as reported in the Summary Compensation Table.